Start for free
Start for free
MC

Medicis Capital

Europe, Bayern, Germany, Munich

Description

Medicis provides capital to innovative teams and companies in the life sciences and healthcare market.

Investor Profile

Medicis Capital has made 6 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series D (33%)
  • Series B (17%)
  • Series C (17%)
  • Series E (17%)
  • Series Unknown (17%)

Country Focus

  • United States (67%)
  • France (17%)
  • United Kingdom (17%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Bioinformatics
  • Health Care
  • Health Diagnostics
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Medicis Capital frequently co-invest with?

Accuitive Medical Ventures
Accuitive Medical Ventures
North America, Georgia, United States, Duluth
Co-Investments: 2
DeNovo Ventures
DeNovo Ventures
North America, California, United States, Saratoga
Co-Investments: 2
Ventech
Ventech
Europe, Ile-de-France, France, Paris
Co-Investments: 2
SV
Saratoga Ventures
North America, California, United States, Santa Clara
Co-Investments: 2
Nexus Medical Partners
Nexus Medical Partners
North America, Massachusetts, United States, Quincy
Co-Investments: 2
Apax Partners
Apax Partners
Europe, England, United Kingdom, London
Co-Investments: 1
HealthCap
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Innoven Partners
Innoven Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Alafi Capital
Alafi Capital
North America, California, United States, San Francisco
Co-Investments: 1
Auriga Partners
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by Medicis Capital?

MyoScience

Redwood City, California, United States

MyoScience develops and commercializes technology-driven dermatological products.

BiotechnologyPharmaceuticalTherapeutics
Series ESep 12, 2013
Amount Raised: $25,000,000
MyoScience

Redwood City, California, United States

MyoScience develops and commercializes technology-driven dermatological products.

BiotechnologyPharmaceuticalTherapeutics
Series DMar 21, 2012
Amount Raised: $33,000,000
Kiora Pharmaceuticals

Salt Lake City, Utah, United States

Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.

BiotechnologyMedicalPharmaceutical
Series DJan 8, 2010
Amount Raised: $22,600,000
Lab21

Cambridge, Cambridgeshire, United Kingdom

Lab21 is a rapidly growing healthcare diagnostics business. The company’s vision is of providing personalised diagnostic testing for

BiotechnologyHealth CareHealth DiagnosticsInformation Technology
Series UnknownMar 18, 2009
Amount Raised: $1,830,702
Kiora Pharmaceuticals

Salt Lake City, Utah, United States

Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.

BiotechnologyMedicalPharmaceutical
Series CMar 12, 2008
Amount Raised: $15,000,000
Hybrigenics

Paris, Ile-de-France, France

Hybrigenics offers a bioinformatics platforms to identify, validate, and inhibit protein interactions to develop therapeutics for cancer.

BioinformaticsBiotechnologyTherapeutics
Series BDec 1, 2001
Amount Raised: $11,611,041
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator